Johnson & Johnson

NYSE: JNJ
$160.88
-$2.79 (-1.7%)
Closing Price on October 25, 2024

JNJ Articles

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day at...
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month bond.  The participation rate was strong enough that this still shows...
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston...
Moody’s cuts ratings of France’s Credit Agricole and Societe Generale as Greek debt trouble spreads. (Reuters) Federal Reserve may try to help the economy with more bond purchases. (Reuters)...
Obama proposes a $447 billion job stimulation package. (Reuters) Economic problems to be the focus of G7 meetings. (Reuters) One Super Congress member threatens to quit over concerns about military...
A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type of arrhythmia by 21% and lowers bleeding...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of June 30, 2011. These public stock holdings have been broken down...
Standard & Poor’s may have done the inevitable move of a U.S. credit ratings downgrade and it may have followed with the downgrade of the insurance companies and with many government agencies...
When you see a ten-day sell-off and a capstone panic day with what is a 300-point sell-off in the Dow Jones Industrial Average, the first reaction is that no one wants anything and that every stock...
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US Food & Drug...
Fitch and Moody’s kept the U.S. rating at Aaa (Reuters) Years of slow growth and aging populations in the West could hasten the rise of BRIC economies (Reuters) Google+ (NASDAQ: GOOG) and the Apple...
The odds that the U.S. will default on its debt on or after August 2 increase each day. Some credit analysts believe the odds are in favor of insolvency. In the event of default, credit rating...
Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may not be...
Next week will mark the true ‘opening the floodgates’ for earnings season.  We have given some brief earnings previews and added in color for the DJIA components set to report earnings in the...
JP Morgan (NYSE: JPM) may become the largest lender in the U.S. soon (Reuters) Jobs numbers may show that the economy has finally turned the corner (Reuters) Fitch downgraded Minnesota from AAA as...